Evaluation of the effectiveness and safety of N-Chromosome Royal Jelly on the number of peripheral white blood cells in patients with acute lymphoblastic leukemia

Gholamreza Bahoush; Rozhin Pahlevani

doi:10.22317/jcms.v6i6.887

Article Details

Evaluation of the effectiveness and safety of N-Chromosome Royal Jelly on the number of peripheral white blood cells in patients with acute lymphoblastic leukemia

Authors:

Gholamreza Bahoush | Rozhin Pahlevani

Publisher:

Nab'a Al-Hayat Foundation for Medical Sciences and Health Care, Iraq

Journal:

Journal of Contemporary Medical Sciences Vol.6 Issue 6, pp.291-295

Document Type:

Article

Publication Date:

12/2020

Document Language:

English

Document ID (Org No.):

2001379383

pISSN:

2413-0516

DOI:

10.22317/jcms.v6i6.887

Keywords:

Abstract:

 Objectives: This study to investigate the immune response blood cells following N-Chromosome RJ administration in patients with childhood ALL.
Methods: This single center before and after 12-weeks clinical trial was done in Ali-Asghar Children Hospital on twenty-six patients diagnosed with ALL during maintenance phase of chemotherapy. After collecting their demographics, patients received a starter dose of 2-gram processed new natural   N-chromosome RJ before breakfast and were followed up each 2 weeks, counting their peripheral WBC, ANC and ALC by a blood cell count and differential analysis.
Results: A total of Twenty-six patients were enrolled in this study (16 males and 10 females). Mean Peripheral WBC count of total patients were raised significantly after administering N-RJ Being 2510 Â±1192 cells per cubic millimeter at the beginning and then raised to 4549Â±1500 cells per cubic millimeter at the end of trial. (P<0.005) None of patients suffered from any adverse reaction during the trial.
There was a positive statistical relationship between total peripheral WBC, ANC and ALC count and N-Chromosome Royal jelly increased dosage, Being more prominent at the beginning of trial (p<0.001) and the last two weeks of follow-ups. (p<0.0005)
Conclusion: This study has successfully demonstrated that N-chromosome RJ can be a promising immune- enhancing supplement in patients diagnosed with acute lymphoblastic leukemia in their complete remission and maintenance therapy time. In addition, it is a natural alternative for drugs like G-CSF, but without those long-term adverse effects, we can see in G-CSF drugs.

Article Details

Evaluation of the effectiveness and safety of N-Chromosome Royal Jelly on the number of peripheral white blood cells in patients with acute lymphoblastic leukemia

Authors:

Gholamreza Bahoush | Rozhin Pahlevani

Publisher:

Nab'a Al-Hayat Foundation for Medical Sciences and Health Care, Iraq

Journal:

Journal of Contemporary Medical Sciences Vol.6 Issue 6, pp.291-295

Document Type:

Article

Publication Date:

12/2020

Document Language:

English

Document ID (Org No.):

2001379383

pISSN:

2413-0516

DOI:

10.22317/jcms.v6i6.887

Acute Lymphoblastic Leukemia

N-Chromosome Royal Jelly

White Blood cell

Issues

Article Details

Evaluation of the effectiveness and safety of N-Chromosome Royal Jelly on the number of peripheral white blood cells in patients with acute lymphoblastic leukemia

Authors: Gholamreza Bahoush | Rozhin Pahlevani

Publisher: Nab'a Al-Hayat Foundation for Medical Sciences and Health Care, Iraq

Journal: Journal of Contemporary Medical Sciences Vol.6 Issue 6, pp.291-295

Document Type: Article

Publication Date: 12/2020

Document Language: English

Document ID (Org No.): 2001379383

pISSN: 2413-0516

DOI: 10.22317/jcms.v6i6.887

Acute Lymphoblastic Leukemia

N-Chromosome Royal Jelly

White Blood cell

Issues

Authors:

Gholamreza Bahoush | Rozhin Pahlevani

Publisher:

Nab'a Al-Hayat Foundation for Medical Sciences and Health Care, Iraq

Journal:

Journal of Contemporary Medical Sciences Vol.6 Issue 6, pp.291-295

Document Type:

Article

Publication Date:

12/2020

Document Language:

English

Document ID (Org No.):

2001379383

pISSN:

2413-0516

DOI:

10.22317/jcms.v6i6.887